Medicare Enrolled
Florida Board Action on Record
The Florida Department of Health has flagged this practitioner's license with a board action.
Verify on FL DOH →
Dr. Mark Pamer, D.O.
Critical Care Medicine · Port Saint Lucie, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Pamer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pamer?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Pamer
Dr. Mark Pamer is a critical care medicine specialist in Port Saint Lucie, FL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Pamer performed 28,409 Medicare services across 3,881 unique beneficiaries.
Between the years covered by Open Payments, Dr. Pamer received a total of $254,153 from 57 pharmaceutical and/or device companies across 1246 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pamer is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 0% volume in FL
$254,153 industry payments
Florida License Status
FL DOH · MQA1
Active license
Yes
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Osteopathic Physician | 9475 | Clear | March 31, 2028 | ⚠ |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗28,409
Medicare services
Top 0% in FL for critical care medicine
3,881
Unique beneficiaries
$29
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,578 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tezepelumab injection, 1 mg An injection of tezepelumab-ekko, a medication administered in 1 mg doses. |
20,580 | $13 | $61 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,906 | $91 | $289 |
| Intravenous immune globulin injection, 500 mg An injection of immune globulin administered into a vein to provide antibodies. The dose specified is 500 mg of non-lyophilized (liquid) immune globulin. |
1,322 | $126 | $469 |
| Outpatient pulmonary rehabilitation with oxygen monitoring A supervised outpatient session for pulmonary rehabilitation that includes continuous monitoring of blood oxygen levels. |
877 | $58 | $153 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
565 | $28 | $127 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
557 | $43 | $134 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
547 | $40 | $124 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
308 | $119 | $384 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
222 | $26 | $70 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
217 | $16 | $110 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
198 | $49 | $210 |
| Nitric oxide gas level test A test that measures the level of nitric oxide gas in the body. |
170 | $14 | $43 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
154 | $11 | $75 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
120 | $17 | $50 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
84 | $4 | $21 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
76 | $127 | $379 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
67 | $13 | $34 |
| Speech and language therapy Treatment for disorders affecting speech, language, voice, communication, and hearing processing. |
64 | $49 | $127 |
| Ultrasound scan of chest An imaging test that uses sound waves to create pictures of the structures inside the chest. |
56 | $39 | $141 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
53 | $54 | $173 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
46 | $140 | $358 |
| Treatment of swallowing and feeding disorder Therapy to address difficulties with swallowing and feeding. This procedure focuses on improving the mechanics and safety of eating and drinking. |
44 | $63 | $138 |
| Inhalation treatment for airway obstruction or sputum production A treatment involving the inhalation of medication to help clear airway obstructions or reduce sputum production. |
37 | $7 | $29 |
| Chest fluid aspiration with imaging guidance This procedure involves removing fluid from the chest cavity using imaging technology to guide the needle placement. |
27 | $247 | $763 |
| Voice box function study A test to evaluate how the voice box is functioning. This procedure assesses the mechanical and physiological performance of the larynx. |
24 | $62 | $118 |
| Voice and resonance analysis Evaluation of how voice and resonance are produced. This procedure assesses the mechanics of sound generation without specifying a clinical purpose. |
24 | $83 | $152 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
16 | $163 | $981 |
| Swallowing evaluation using an endoscope This procedure involves using an endoscope to visually evaluate and record the swallowing process. |
14 | $141 | $280 |
| New patient office visit, complex (60-74 min) | 12 | $165 | $328 |
| Vocal cord movement assessment with endoscope This procedure uses an endoscope to examine the movement of the vocal cords. It allows for the visual assessment of how the vocal cord flaps function. |
11 | $156 | $347 |
| Exercise stress test A test that monitors the heart and lungs while the patient exercises to evaluate their function under physical stress. |
11 | $113 | $257 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.6% high complexity
79.2% medium
19.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$254,153
Total received (2018-2024)
Avg $36,308/year across 7 years
Top 2% in FL for critical care medicine
57
Companies
1,246
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$171,839 (67.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$65,343 (25.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,971 (6.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$23,471
2023
$69,666
2022
$45,842
2021
$20,430
2020
$17,998
2019
$47,392
2018
$29,353
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Mylan Specialty L.P.
$186,695
AstraZeneca Pharmaceuticals LP
$16,766
Sunovion Pharmaceuticals Inc.
$16,295
Circassia Pharmaceuticals Inc
$10,848
Grifols USA, LLC
$8,346
Actelion Pharmaceuticals US, Inc.
$1,896
GlaxoSmithKline, LLC.
$1,519
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,288
United Therapeutics Corporation
$1,065
GENZYME CORPORATION
$945
Takeda Pharmaceuticals U.S.A., Inc.
$905
Electromed, Inc.
$827
PFIZER INC.
$735
Regeneron Healthcare Solutions, Inc.
$596
Genentech USA, Inc.
$418
Shire North American Group Inc
$398
Philips Electronics North America Corporation
$375
Amgen Inc.
$340
Baxter Healthcare
$339
Insmed, Inc.
$328
CSL Behring
$294
Octapharma USA, Inc.
$293
Bayer HealthCare Pharmaceuticals Inc.
$262
Novartis Pharmaceuticals Corporation
$216
Teva Pharmaceuticals USA, Inc.
$192
JAZZ PHARMACEUTICALS INC.
$164
Janssen Biotech, Inc.
$134
Medtronic, Inc.
$132
Advanced Respiratory, Inc
$125
Gilead Sciences, Inc.
$118
Merck Sharp & Dohme LLC
$104
SANOFI-AVENTIS U.S. LLC
$100
ADVANCED RESPIRATORY, INC
$98
Medline Industries, Inc.
$83
Vifor Pharma, Inc.
$82
Paratek Pharmaceuticals, Inc.
$76
UCB, Inc.
$67
Mallinckrodt Enterprises LLC
$66
Novo Nordisk Inc
$64
Mallinckrodt Hospital Products Inc.
$56
Pulmonx Corporation
$53
Axsome Therapeutics, Inc.
$52
Inspire Medical Systems, Inc.
$42
RECORDATI_RARE_DISEASES_INC.
$40
OptiNose US, Inc.
$39
Fisher & Paykel Healthcare Inc
$30
Jazz Pharmaceuticals Inc.
$29
Aurinia Pharma U.S., Inc.
$28
Lilly USA, LLC
$26
Philips North America LLC
$24
ABBVIE INC.
$23
Atos Medical Inc
$23
Optinose US, Inc.
$22
Horizon Therapeutics plc
$21
Sandoz Inc.
$19
Eisai Inc.
$16
ARBOR PHARMACEUTICALS, INC.
$15
Top 3 companies account for 86.5% of total payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · Adempas · AirDuo Digihaler · Arikayce · ArmonAir Digihaler · BEVESPI AEROSPHERE · BREO · BREZTRI · CAPVAXIVE · CHANTIX · CHARTIS CATHETER · CINQAIR · CINRYZE · CUTAQUIG · Cimzia · DUAKLIR PRESSAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dayvigo · Enbrel · Esbriet · FASENRA · FISHER & PAYKEL HEALTHCARE · GAMMAGARD · GLASSIA · Gamunex-C · HYQVIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · Hillrom - Volara System · Horizant · ILLUMISITE · INSPIRE · KEYTRUDA · LONHALA MAGNAIR · LUPKYNIS · Life 2000 Ventilation System · NIOX VERO · NIOX VERO DEVICE · NUCALA · NUZYRA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Ozempic · PANZYGA · PAXLOVID · PREVNAR - 13 · PREVNAR 20 · Perforomist · Prolastin-C · Prolastin-C Liquid · RAYOS · REMICADE · REMODULIN · RYBELSUS · Respiratoriy Care Undiv · Rituxan · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYLVANT · SYMBICORT · Saxenda · Sunosi · TALTZ · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TREPROSTINIL · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · UTIBRON · UTIBRON NEOHALER · WINREVAIR · Wellcentive Undiv · XOLAIR · XYWAV · Xembify · Xhance · Xolair · YUPELRI · Yupelri · Zemaira · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (68%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in critical care medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for critical care medicine in FL.
Equivalent to $895 per 100 Medicare services performed
Geographic Context
Critical care medicines within 10 mi
18
Per 100K population
5.2
County median income
$69,027
Nearest hospital
ST LUCIE MEDICAL CENTER
6.7 mi
6.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Pamer is a mixed practice specialist, with above-average Medicare volume (top 0% in FL), with speaking/promotional industry engagement in the top 2% of FL peers, with 18 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Pamer experienced with tezepelumab injection, 1 mg?
Based on Medicare claims data, Dr. Pamer performed 20,580 tezepelumab injection, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pamer receive payments from pharmaceutical companies?
Yes. Dr. Pamer received a total of $254,153 from 57 companies across 1,246 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pamer's costs compare to other critical care medicines in Port Saint Lucie?
Dr. Pamer's average Medicare payment per service is $29. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pamer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Port Saint Lucie
Browse critical care medicines in Port Saint Lucie ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in FL
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in FL
Which FL critical care medicines receive the most from drug and device companies.
By company
Mylan Specialty L.P. Payments to Doctors
See all physicians who received payments from Mylan Specialty L.P.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Sunovion Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Sunovion Pharmaceuticals Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology